![Foto de Vivencio Vicente](/img/nophoto.png)
Vivencio Vicente
Barrios Alonso
Profesor/a Asociado/a en CC. de la Salud
Publications (460) Vivencio Vicente Barrios Alonso publications
2024
-
Central American and Caribbean Consensus Document for the Optimal Management of Oral Anticoagulation in Patients with Non-Valvular Atrial Fibrillation Endorsed by the Central American and Caribbean Society of Arterial Hypertension and Cardiovascular Prevention
Journal of Clinical Medicine, Vol. 13, Núm. 2
-
Characteristics of women with type 2 diabetes mellitus and heart failure in Spain. The DIABET-IC study
Cardiology Journal, Vol. 31, Núm. 1, pp. 103-110
-
Diagnóstico y tratamiento de los pacientes con ANOCA Consenso SEC-Asociación de Cardiología Clínica/ SEC-Asociación de Cardiología Intervencionista/ SEC-Asociación de Cardiopatía Isquémica y Cuidados Agudos Cardiovasculares/SEC-Asociación de Imagen Cardiaca
REC: Interventional Cardiology, Vol. 6, Núm. 2, pp. 106-116
-
Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial
Endocrinologia, Diabetes y Nutricion
-
New technologies for the diagnosis, treatment, and monitoring of cardiovascular diseases
Revista Espanola de Cardiologia, Vol. 77, Núm. 1, pp. 88-96
-
Post-event follow-up costs in patients with atherosclerotic cardiovascular disease in Spain
Frontiers in Cardiovascular Medicine, Vol. 11
2023
-
Association between sacubitril/valsartan initiation and changes in left ventricular ejection fraction: Insights from ARIADNE registry
International Journal of Cardiology, Vol. 370, pp. 279-286
-
Cardiovascular Risk in Patients with Dyslipidemia and Their Degree of Control as Perceived by Primary Care Physicians in a Survey—TERESA-Opinion Study
International Journal of Environmental Research and Public Health, Vol. 20, Núm. 3
-
Cardiovascular toxicity of checkpoint inhibitors: review of associated toxicity and design of the Spanish Immunotherapy Registry of Cardiovascular Toxicity
Clinical and Translational Oncology, Vol. 25, Núm. 11, pp. 3073-3085
-
Cost-effectiveness of the CNIC-Polypill versus separate monocomponents in cardiovascular secondary prevention in Spain
Revista Clinica Espanola, Vol. 223, Núm. 7, pp. 414-422
-
Current situation of the comprehensive approach of heart failure in Spain. The OPTIMISE-IC project
REC: CardioClinics, Vol. 58, Núm. 4, pp. 289-302
-
Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain
Journal of Clinical Medicine, Vol. 12, Núm. 16
-
Impact of COVID-19 pandemic on the sanitary assistance of atrial fibrillation in Spain
REC: CardioClinics, Vol. 58, Núm. 3, pp. 241-244
-
Impact of the Spanish consensus for improving lipid control on patients admitted for an acute coronary syndrome
Journal of Clinical Lipidology, Vol. 17, Núm. 6, pp. 756-764
-
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban
Journal of comparative effectiveness research, Vol. 12, Núm. 3, pp. e220049
-
Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN Study
Medicina (Lithuania), Vol. 59, Núm. 10
-
Real-World Attainment of Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Cardiovascular Disease Treated with High-Intensity Statins: The TERESA Study
Journal of Clinical Medicine, Vol. 12, Núm. 9
-
SGLT 2 inhibitors: Searching for the best in class
International Journal of Cardiology
-
STRUGGLE FOR. Italian-Polish-Spanish-Uzbek--Vietnamese Expert Forum Position Paper 2023 for better control of classical modifiable risk factors in clinical practice
Cardiology Journal, Vol. 30, Núm. 6, pp. 859-869
-
Selection of the best of 2022 in clinical cardiology and cardiovascular pharmacotherapy
REC: CardioClinics, Vol. 58, pp. S49-S54